AlphAIalphai — Financial news for AI agents
SEC EDGARMAY 281 min read$TRUP

Tooth Margaret sold $11K of TRUP

Tooth Margaret (CEO) sold 491 shares of TRUPANION, INC. (TRUP) at $21.86 on 2026-05-25.

Original reporting
SEC EDGAR · Tooth Margaret
Published May 28, 2026, 1:41 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai May 28, 2026, 2:03 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
alphai market briefInsider activity
Primary signal
$TRUP
Neutral
medium confidence
Mentioned
$TRUP
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$TRUPNeutralLow
01

Why it matters

This is an ownership-change event: the CEO executed an open-market sale of 491 shares at a stated price, which may briefly affect sentiment but does not provide new operational or financial information.

02

Market read

Traders may monitor insider-flow for sentiment, but absent a fundamental catalyst, expected price reaction is typically muted.

03

What to watch

No 10b5-1 plan is cited, but the filing alone doesn’t reveal intent; without follow-on filings or operational news, trading impact should be discounted.

Relevance 6/10Timing: Immediate (today/next session) as traders may react to insider-flow headlines; otherwise low follow-through risk.

Background

The article is an SEC Form 4 insider transaction disclosure for TRUPANION, INC. (TRUP).

Company-level read

Ticker impact

$TRUPNeutralMedium confidence
Context

TRUP CEO sold 491 shares in an open-market transaction at $21.86 on 2026-05-25, disclosed via SEC Form 4.

Expected impact

Likely limited, short-lived impact; any move would be more sentiment-driven than thesis-driven.

Evidence & confidence

The filing is an officer/director open-market sale with no 10b5-1 plan stated, but the article provides no accompanying company-specific catalyst (earnings, guidance, deal, or litigation).

Market effects

Sector

Minimal; this is company-specific insider activity without sector-wide information.

Regional

None indicated.

Global

None indicated.

Counterpoint

What could challenge this read

The sale could be routine liquidity/portfolio management rather than a negative view, especially given the small share count relative to holdings.

Key entities

  • issuer
    TRUPANION, INC.

    Company whose CEO reported an open-market sale of 491 shares via SEC Form 4.

  • insider
    Tooth Margaret

    CEO/officer/director who sold shares; filing includes post-transaction holdings.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

TRUP insider trading history →

Related articles

AUG 26
$TRUPMed

Why Trupanion (TRUP) Shares Are Sliding Today

Trupanion (TRUP) shares fell 5.8% after Piper Sandler downgraded the stock to Neutral, citing challenges in the pet insurance market and rising claim costs. The firm lowered its price target to $32 from $45. The stock has seen significant volatility, down 19.6% year-to-date and 35.6% from its 52-week high.

financialcontent.com2 min
AUG 26
$TRUPHigh

Why is Trupanion stock sliding today?

Trupanion stock fell 6.4% after Piper Sandler downgraded it to Neutral and cut its price target to $32 from $45, citing revenue and margin pressures. Zacks Research also downgraded the stock, amplifying the selloff. The company's shares have retreated from their 52-week high of $46.98, trading near the 52-week low of $21.16.

investing.com2 min
AUG 15
$TRUPMed

Trupanion (TRUP) Is Up 13.4% After New Vet Partnerships and Q2 Results - Has The Bull Case Changed?

Trupanion reported Q2 2026 results with net income of $6.83 million and updated revenue guidance, and it announced new partnerships and integrations with Digitail and Home To Home. The article links VetDirect Pay and Exam Day coverage to pet-care workflows and discusses margin and subscription growth targets, including projected $2.0 billion revenue and $36.5 million earnings by 2029.

simplywall.st7 min
AUG 6
$METMed

Financial results round-up: MetLife, Prudential, Corebridge, Palomar, Heritage, TWFG, Root and more

A financial results roundup covers multiple insurers and MGAs. MetLife reported Q2 net income of $705m and adjusted EPS $2.43. Prudential posted Q2 net income of $985m and record individual life sales. Corebridge reported a $16m net loss and merger approval. Palomar, Heritage, TWFG, Root, Trupanion and Clover Health also reported Q2 figures and guidance updates.

insurancebusinessmag.com9 min
AUG 5
$TRUPMed

TRUPANION, INC. (TRUP): Results of Operations and Financial Condition

TRUPANION, INC. (TRUP) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Trupanion Reports Second Quarter 2026 Results Authorizes Share Repurchase Program SEATTLE, WA. August 5, 2026 -- Trupanion , Inc. (Nasdaq: TRUP), a leading provider of medical insurance for cats and dogs, today announced financial results for the second quarter ended

SEC EDGAR 8-K6 min